News Digest / Ticker: HROW

Ticker: HROW

06:26am, Friday, Aug 09, 2024

Harrow Health Reports 46% Revenue Surge in Q2 2024, Eyes Future Growth in Ophthalmics

Harrow Health (NASDAQ: HROW) reported a 46% revenue increase to $48.9M in Q2 2024, driven by its Anterior Segment business. CEO Mark Baum highlighted strong growth in branded products and plans for expanded sales efforts. Positive outlook on 2024 growth amidst cautious projections.